UK health secretary Wes Streeting resigns
UK health secretary Wes Streeting has resigned, citing a ‘loss of faith’ in the Labour party’s leadership under Prime Minister…
All articles by Ross Law
Ross Law
Ross Henry Law is a reporter for Medical Device Network. His key interest areas in healthcare include regulation, mental health, neurology, oncology, and Alzheimer's disease. Ross also has extensive prior experience in covering the captive insurance, retail, and technology sectors.
-
-
Why single biomarkers are no longer enough: a new paradigm in colorectal cancer
In colorectal cancer (CRC), biomarkers have long been used to decide if patients are eligible for a particular therapy or…
-
500,000 patients’ data for sale online after UK Biobank breach
Last week, data from 500,000 participants of UK Biobank’s database were made available for sale online following a breach, the…
-
Xeltis gains EU CE mark on positive trial data for vascular access graft
Xeltis has gained a European CE mark for aXess, with 12-month pivotal data of the vascular access graft for haemodialysis…
-
TRiCares gains FDA IDE to initiate tricuspid regurgitation treatment pivotal trial
TRiCares has been granted an investigational device exemption (IDE) by the US Food and Drug Administration (FDA) to initiate a…
-
Boston Scientific presents Watchman FLX and EKOS endovascular system data
Boston Scientific has shared a duo of positive data readouts from two separate trials evaluating its Watchman FLX left atrial appendage…
-
Enhancing clinical trials with real-world data
Sujay Jadhav, CEO of Verana Health highlights how real-time real-world data dashboards are transforming the way life sciences organisations understand…
-
Technology a key tool in successful clinical supply management
The clinical trial supply chain comprises of many stakeholders, including the originating pharma company or biotech, vendors, logistics companies, contract…
-
Strong relationships among stakeholders key to clinical supply chain success
Pharmaceutical companies increasingly require more scalability and precision in managing their clinical supply chain. Such demands necessitate stronger, more impactful…
-
The clinical trial supply model of the future
Existing clinical trial supply models are facing a number of challenges - increased market competition, growing trial complexity, a significant…